A diagnosis of cancer is a period filled with immense stress and uncertainty. Patients are thrust into a treatment journey filled with numerous medical interventions, a continuously changing treatment strategy, and unforeseen complications. Furthermore, patients grapple with uncertainties surrounding the logistics of their care, including location, timing, and financial implications.
The frequency of such scenarios is on the rise. Digital health innovations play a pivotal role in aiding patients to navigate the intricate landscape of cancer treatment. Digital health solutions are designed to complement pharmaceutical interventions and medical equipment, offering patients access to interventions and recommendations grounded in scientific evidence. In this article, Sophie Opdyke, Merck’s Senior Vice President of Global Marketing Oncology, shared insights on how digital health technologies are poised to empower pharmaceutical and healthcare provider organizations to enhance the patient experience amidst the challenging journey of cancer treatment.
“*” indicates required fields